136 related articles for article (PubMed ID: 10932054)
1. [Comparison of the modified Jaffé method and an enzymatic method for the measurement of serum creatinine: practical consequences of a method change in the milieu of laboratory of oncologic clinical biology].
Jaudon T; Séronie-Vivien S; Chatelut é ; Chanut C; Favre G
Ann Biol Clin (Paris); 2000; 58(4):499-504. PubMed ID: 10932054
[No Abstract] [Full Text] [Related]
2. [Determination of individual kidney function?].
Lipp HP
Med Monatsschr Pharm; 2008 Oct; 31(10):393-5. PubMed ID: 18975414
[No Abstract] [Full Text] [Related]
3. Glomerular filtration rate estimates based on serum creatinine level in healthy people: conventional Jaffe method versus calibrated Jaffe method at laboratories in Rasht.
Badeli H; Sadeghi M; Khalili Pour E; Heidarzadeh A
Iran J Kidney Dis; 2009 Jan; 3(1):45-9. PubMed ID: 19377259
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Jaffé rate assay and enzymatic method for the measurement of creatinine clearance.
Horio M; Orita Y
Nihon Jinzo Gakkai Shi; 1996 Jul; 38(7):296-9. PubMed ID: 8741390
[TBL] [Abstract][Full Text] [Related]
5. Determination of reference intervals for serum creatinine, creatinine excretion and creatinine clearance with an enzymatic and a modified Jaffé method.
Junge W; Wilke B; Halabi A; Klein G
Clin Chim Acta; 2004 Jun; 344(1-2):137-48. PubMed ID: 15149882
[TBL] [Abstract][Full Text] [Related]
6. Do enzymatic and Jaffé creatinine assays produce comparable results for pre and post dialysis specimens from patients with chronic renal failure?
Rumbelow BD; Peake MJ; Ehrhardt V
Clin Lab; 2000; 46(11-12):589-90. PubMed ID: 11109507
[No Abstract] [Full Text] [Related]
7. [Interference of clavulanic acid in the assay of creatinine using the Jaffe method on the Dade/RXL analyzer].
Hanser AM; Parent X
Ann Biol Clin (Paris); 2000; 58(6):735-7. PubMed ID: 11098171
[No Abstract] [Full Text] [Related]
8. [Determination of serum creatinine by gas-liquid chromatography].
Ambert JP; Hartmann L
C R Seances Soc Biol Fil; 1985; 179(5):600-7. PubMed ID: 2938687
[TBL] [Abstract][Full Text] [Related]
9. [Direct estimation of creatinine in serum and in urine without deproteinization using a modified Jaffé method].
Helger R; Rindfrey H; Hilgenfeldt J
Z Klin Chem Klin Biochem; 1974 Jul; 12(7):344-9. PubMed ID: 4428848
[No Abstract] [Full Text] [Related]
10. Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method.
Allegaert K; Kuppens M; Mekahli D; Levtchenko E; Vanstapel F; Vanhole C; van den Anker JN
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1678-81. PubMed ID: 22273037
[TBL] [Abstract][Full Text] [Related]
11. New data on the intraindividual variation of cystatin C.
Delanaye P; Cavalier E; Depas G; Chapelle JP; Krzesinski JM
Nephron Clin Pract; 2008; 108(4):c246-8. PubMed ID: 18391572
[TBL] [Abstract][Full Text] [Related]
12. A Risk Assessment of the Jaffe vs Enzymatic Method for Creatinine Measurement in an Outpatient Population.
Schmidt RL; Straseski JA; Raphael KL; Adams AH; Lehman CM
PLoS One; 2015; 10(11):e0143205. PubMed ID: 26599086
[TBL] [Abstract][Full Text] [Related]
13. Standardization of serum creatinine and estimated GFR in the Kidney Early Evaluation Program (KEEP).
Stevens LA; Stoycheff N
Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S77-82. PubMed ID: 18359411
[TBL] [Abstract][Full Text] [Related]
14. Dose individualization can minimize nephrotoxicity due to carboplatin therapy in patients with ovarian cancer.
Donadio C; Lucchesi A; Ardini M; Cosio S; Fanucchi A; Gadducci A
Ther Drug Monit; 2009 Feb; 31(1):63-9. PubMed ID: 19077927
[TBL] [Abstract][Full Text] [Related]
15. Multi-institutional validation study of carboplatin dosing formula using adjusted serum creatinine level.
Ando M; Minami H; Ando Y; Saka H; Sakai S; Yamamoto M; Sasaki Y; Shimokata K; Hasegawa Y
Clin Cancer Res; 2000 Dec; 6(12):4733-8. PubMed ID: 11156227
[TBL] [Abstract][Full Text] [Related]
16. [Method selected for the determination of creatinine in plasma or serum. Choice of optimal conditions of measurement].
Labbé D; Vassault A; Cherruau B; Baltassat P; Bonète R; Carroger G; Costantini A; Guérin S; Houot O; Lacour B; Nicolas A; Thioulouse E; Trépo D
Ann Biol Clin (Paris); 1996; 54(8-9):285-98. PubMed ID: 9092308
[TBL] [Abstract][Full Text] [Related]
17. Flat dosing of carboplatin is justified in adult patients with normal renal function.
Ekhart C; de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
Clin Cancer Res; 2006 Nov; 12(21):6502-8. PubMed ID: 17085665
[TBL] [Abstract][Full Text] [Related]
18. Impact of serum creatinine measurement error on dose adjustment in renal failure.
Schneider V; Henschel V; Tadjalli-Mehr K; Mansmann U; Haefeli WE
Clin Pharmacol Ther; 2003 Nov; 74(5):458-67. PubMed ID: 14586386
[TBL] [Abstract][Full Text] [Related]
19. Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays?
Vickery S; Stevens PE; Dalton RN; van Lente F; Lamb EJ
Nephrol Dial Transplant; 2006 Sep; 21(9):2439-45. PubMed ID: 16720592
[TBL] [Abstract][Full Text] [Related]
20. Impact of the biochemical assay for serum creatinine measurement on the individual carboplatin dosing: a prospective study.
Léger F; Séronie-Vivien S; Makdessi J; Lochon I; Delord JP; Sarda C; Canal P; Chatelut E
Eur J Cancer; 2002 Jan; 38(1):52-6. PubMed ID: 11750839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]